• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Autoantibody response to adjuvant and non-adjuvant H1N1 vaccination in SLE

tetano

Editor, Senior Moderator
Autoantibody response to adjuvant and non-adjuvant H1N1 vaccination in SLE

Murray B. Urowitz MD, FRCP(C),
Anoja Anton MD,
Dominique Ibanez MSc,
Dafna D. Gladman MD, FRCPC,?

DOI: 10.1002/acr.20599


Abstract
Objective:

It has been reported that influenza vaccination increases autoantibody production and/or disease activity in a significant proportion of patients with SLE. During the recent H1N1 epidemic, we investigated whether the use of adjuvant and non-adjuvant containing H1N1 vaccine induced increased autoantibody production in patients with SLE.
Methods:

Patients with SLE who received H1N1 vaccination and had a battery of 9 autoantibodies tested before 1 and 3 months after vaccination were included. Antibodies tested included rheumatoid factor (nephelometry), antinuclear antibody (immunofluorescence), anti-DNA (Farr), anti-RNP, anti-SM, anti-Ro, anti-La, anti-Scl70 and anti-Jo1 (ELISA). Patients were evaluated by standard protocol including items necessary to calculate SLEDAI-2K and SDI. Descriptive statistics and McNemar test were performed to evaluate change in antibodies positivity. Multivariate logistic regression was preformed to adjust for repeated measures in the comparisons of autoantibody over visits and vaccine types.
Results:

103 patients (94F, 9M), with mean age at vaccination of 43.9 (?15.2) years, disease duration 14.2 (?11.0) years were included. 51 patients received adjuvant and 52 non-adjuvant vaccines. Antibody testing was performed a mean of 1.9 months prior to the vaccination. First post-vaccination sample was taken a mean of one month and the second a mean of 3.5 months after vaccination. The percent of patients with changes in antibodies following vaccination was not statistically significant for most antibodies. After adjusting for the number of tests performed none of the associations was significant.
Conclusion:

H1N1 vaccination (both adjuvant and non adjuvant) did not increase the levels of autoantibodies in patients with SLE. ? 2011 by the American College of Rheumatology.

http://onlinelibrary.wiley.com/doi/...+3+Sep+from+10-12+BST+for+monthly+maintenance
 
Back
Top Bottom